Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2005

Outcome of scleral buckling for primary rhegmatogenous retinal detachment inNigeria.

Mahmoud Alhassan, Mansur Rabiu, Yinka Olongusua, Abubakar Ahmed

Med Sci Monit 2005; 11(12): CR589-593 :: ID: 438857


Background: The goal was to review the visual and anatomical outcome ofscleral buckling for primary rhegmatogenous retinal detachment at a tertiary eye care center in Nigeriabetween January 1994 and December 2000. Material/Methods: This was a retrospective, descriptive caseseries of all eyes that had undergone scleral buckling over a 7-year study period. Data collected fromthe case notes included duration of symptoms, visual acuity at presentation and 3 and 6 months post-op,clinical presentation of the detachments, risk factors for retinal detachment, the surgical proceduredone, anatomical outcome at discharge and at 3 and 6 months post-op, and intra-op and post-op complications.Results: Ninety-eight eyes of 98 patients underwent scleral buckling for primary rhegmatogenous retinaldetachment during the study period. The mean age was 42 years. The male-to-female ratio was 3.7:1. Themean duration of symptoms was 29.7 weeks. Seventy-six eyes (77.6%) had subtotal to total retinal detachment,with 91 (92.9%) eyes having macular detachment. The surgical technique was cryotherapy, sub-retinal fluiddrainage, and explant. At 3 months post-op, 40/54 (74.1%) eyes had successful anatomical outcome. Only52% (21/40) of these eyes had the best corrected visual acuity of 6/60 or better at 3 months post-op.Conclusions: In Nigeria, and possibly many developing countries, efforts should be made towards earlydiagnosis and treatment of retinal detachments with adequate expertise and facilities.

Keywords: Adolescent, Child, Nigeria, Retinal Detachment - surgery, Scleral Buckling

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

17 Mar 2024 : Clinical Research  

Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942667  


27 Mar 2024 : Clinical Research  

Impact of Patient Education Formats on Treatment Adherence and Denture Hygiene in Edentulous Patients: A Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944175  

27 Mar 2024 : Clinical Research  

Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.944114  

15 May 2024 : Database Analysis  

MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB

Med Sci Monit In Press; DOI: 10.12659/MSM.944685  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750